Emerald Finance has hit its upper circuit limit at Rs. 69.35, marking an increase of 3.30 points or 5.00% from its previous close of Rs. 66.05 on the BSE.

The stock opened at Rs. 69.35 and maintained this peak throughout the trading session. A total of 36,318 shares have exchanged hands so far.

The BSE group 'XT' stock, with a face value of Rs. 10, has achieved a 52-week high of Rs. 69.35 on July 25, 2024, and a 52-week low of Rs. 18.05 on October 4, 2023.

Over the past week, the stock's high and low were Rs. 69.35 and Rs. 47.26 respectively. The company’s current market capitalization stands at Rs. 209.05 crore.

The promoters hold 67.80% of the company's shares, while institutional and non-institutional investors own 1.31% and 30.90% respectively.

Emerald Finance has entered into a partnership with Cadchem Laboratories to implement an Early-Wage-Access program for the pharmaceutical company's employees. Cadchem Laboratories specializes in the development and production of niche Active Pharmaceutical Ingredients (APIs) and their intermediates.

This collaboration aims to provide employees with instant financial relief by enabling access to a portion of their salaries at any time during the month. Emerald Finance has been developing a salary advance solution to expand its services and better serve retail customers. This product involves offering short-term loans as salary advances, with the amount repaid through salary deductions.

As a Non-Banking Financial Company (NBFC), Emerald Finance focuses on providing financial services to small and medium enterprises (SMEs) in both corporate and non-corporate sectors.